EHS
EHS

DailyMed – MECLIZINE HYDROCHLORIDE tablet


Administration Instructions

Advise patients that the tablets must be swallowed whole

[see Dosage and Administration (

2.2)]

.

Adverse Reactions

Advise patients that meclizine hydrochloride tablets may cause anaphylactic reaction, drowsiness, dry mouth, headache, fatigue, vomiting and, on rare occasions, blurred vision

[see Warnings and Precautions (

5.1), Adverse Reactions (

6)]

.

Inform patients that meclizine hydrochloride tablets may impair their ability to engage in potentially dangerous activities, such as operating machinery or vehicles.

Concomitant Drug Interactions

Advise patients regarding medications that should not be taken in combination with meclizine hydrochloride tablets or that may necessitate increased monitoring

[see Drug Interactions (

7.1,

7.2)]

. Inform patients that alcohol may increase adverse reactions.

Concurrent Medical Conditions

Advise patients to notify their healthcare provider about all of their medical conditions, including if they are pregnant or plan to become pregnant or if they are breastfeeding

[see Warnings and Precautions (

5.2), Use in Specific Populations (

8.1,

8.2)]

.

Manufactured by:

ANI Pharmaceuticals Canada, Inc.

Oakville, ON L6H 1M5

Canada

Distributed by:

ANI Pharmaceuticals, Inc.

Baudette, MN 56623

N6820 Rev 01/21



Source link

EHS
Back to top button